InMed Pharmaceuticals Inc (INM)

[lesgetrich]

They've at least verified that the company is alive and well and still on schedule. From their presentation...

InMed Investor Presentation

InMed will be conducting clinical trials by mid-2016, and will have early clinical efficacy results by late 2016

Phase 1/2 Trials of INM-750 are scheduled to start this quarter.

InMed’s Phase 1/2a Clinical Trial

• Single center trial based in the EU
- Patient recruitment base already identified

• 5-6 patients treated for 4-6 weeks

• Placebo control, in which patients act as
their own control

• Primary endpoint:
- Target wound size reduction

• Secondary Endpoints:
- Physician overall assessment
- Number of blisters
- Skin structure biopsy

Their last PR about seeking other business opportunities leads me to believe that they're looking into commercializing their biosynthesis process for producing phytocannabinoids for its product candidates. This could be a source of funding to complete their trials.